Protective effects of propranolol on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats.
D000311:Adrenal Glands / Q000473:pathology; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001161:Arteriosclerosis / Q000150:complications*; D001219:Aspartate Aminotransferases / Q000097:blood; D001322:Autoanalysis; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D007515:Islets of Langerhans / Q000473:pathology; D007545:Isoproterenol; D007668:Kidney / Q000473:pathology; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced*; D009206:Myocardium / Q000473:pathology; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D013950:Thymus Gland / Q000473:pathology; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D002784:Cholesterol; D011433:Propranolol; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D007545:Isoproterenol